Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mexico
Mexico: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 78.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mexico, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Mexico is 78.0%, measured in 2025.
Compared with earlier readings it is up 2.6% on the previous year and down 16.1% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Mexico peaked at 99.0% in 2012 and was at its lowest, 14.0%, in 2008.
That places Mexico 123rd out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mexico, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 14.0% | — |
| 2009 | 46.0% | +228.6% |
| 2010 | 92.0% | +100.0% |
| 2011 | 98.0% | +6.5% |
| 2012 | 99.0% | +1.0% |
| 2013 | 84.0% | -15.2% |
| 2014 | 94.0% | +11.9% |
| 2015 | 93.0% | -1.1% |
| 2016 | 92.0% | -1.1% |
| 2017 | 92.0% | +0.0% |
| 2018 | 88.0% | -4.3% |
| 2019 | 86.0% | -2.3% |
| 2020 | 77.0% | -10.5% |
| 2021 | 83.0% | +7.8% |
| 2022 | 84.0% | +1.2% |
| 2023 | 78.0% | -7.1% |
| 2024 | 76.0% | -2.6% |
| 2025 | 78.0% | +2.6% |
Mexico compared with similar countries
- Mexico's 78.0% is above the median for upper middle income countries, which is 76.0%, 1.0× the median. (57 countries reporting)
- Mexico's 78.0% is below the median for Latin America & Caribbean, which is 82.5%, 95% of the median. (32 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mexico changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +228.6% | 14.0% | 46.0% |
| 2010 | +100.0% | 46.0% | 92.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 30.0% | 14.0% | 46.0% | 2 |
| 2010s | 91.8% | 84.0% | 99.0% | 10 |
| 2020s | 79.3% | 76.0% | 84.0% | 6 |
Countries ranked near Mexico
More health data for Mexico
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,312 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,760 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.9607 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0377 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.9678 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Mexico?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Mexico was 78.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mexico?
- The highest recorded value was 99.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mexico?
- The lowest recorded value was 14.0% in 2008.
- How does Mexico rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mexico ranks 123rd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Mexico?
- Over the last ten years it is down 16.1%. The long-run trend across the full record is rising.
- Where does this Mexico data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).